PFE licenses China-only commercial rights_to (another) GLP-1 agonist: https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-diabetes-drug-deal-with-sciwind-biosciences-2026-02-24/ https://www.sciwindbio.com/portal/index/newsdetail/id/123/category_id/5.html